Contact this trialFirst, we need to learn more about you.
GRI-0621 for Pulmonary Fibrosis
Recruiting0 awardsPhase 2
Phoenix, Arizona
This trial is testing a new drug called GRI-0621 in patients with idiopathic pulmonary fibrosis (IPF). It is a Phase 2a study where 36 subjects will be randomly
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service